4.3 (7)
The MS Society in the U.K. is hoping to raise £3.7 million ($5.2 million) to fund research aimed at developing new treatments for multiple sclerosis (MS).
The funds will support research at the Society’s Centers of Excellence in Edinburgh and Cambridge over five years.
“Our top priority is finding treatments that slow or stop MS for everyone,” Emma Gray, PhD, assistant director of research at the MS Society, said in a press release. “The work happening in Cambridge and Edinburgh is inventive, innovative and incredibly exciting, and will be vital to help us reach our goal.”
MS is caused by immune cells attacking the body’s own myelin, a fatty insulation that covers the long branches, called axons, that extend from nerve cells. When myelin is destroyed a process called demyelination the connections between neurons become defective and MS symptoms arise.
Cambridge set to be new hub for multiple sclerosis research cambridge-news.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cambridge-news.co.uk Daily Mail and Mail on Sunday newspapers.